Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 132 | 7 | 5.3 | 44 | 33.3 | 45 | 34.1 | 19 | 14.4 | 17 | 12.9 |
2015-2019 | 128 | 7 | 5.5 | 49 | 38.3 | 39 | 30.5 | 14 | 10.9 | 19 | 14.8 |
2014-2018 | 129 | 5 | 3.9 | 52 | 40.3 | 38 | 29.5 | 14 | 10.9 | 20 | 15.5 |
2013-2017 | 121 | 5 | 4.1 | 45 | 37.2 | 37 | 30.6 | 11 | 9.1 | 23 | 19.0 |
2012-2016 | 110 | 4 | 3.6 | 45 | 40.9 | 35 | 31.8 | 11 | 10.0 | 15 | 13.6 |
2011-2015 | 120 | 4 | 3.3 | 49 | 40.8 | 39 | 32.5 | 13 | 10.8 | 15 | 12.5 |
2010-2014 | 120 | 7 | 5.8 | 46 | 38.3 | 38 | 31.7 | 15 | 12.5 | 14 | 11.7 |
2009-2013 | 119 | 10 | 8.4 | 46 | 38.7 | 33 | 27.7 | 16 | 13.4 | 14 | 11.8 |
2008-2012 | 134 | 14 | 10.4 | 49 | 36.6 | 38 | 28.4 | 23 | 17.2 | 10 | 7.5 |
2007-2011 | 139 | 21 | 15.1 | 45 | 32.4 | 38 | 27.3 | 24 | 17.3 | 11 | 7.9 |
2006-2010 | 139 | 26 | 18.7 | 42 | 30.2 | 39 | 28.1 | 22 | 15.8 | 10 | 7.2 |
2005-2009 | 154 | 38 | 24.7 | 47 | 30.5 | 42 | 27.3 | 18 | 11.7 | 9 | 5.8 |
2004-2008 | 159 | 39 | 24.5 | 48 | 30.2 | 49 | 30.8 | 14 | 8.8 | 9 | 5.7 |
2003-2007 | 155 | 41 | 26.5 | 52 | 33.5 | 42 | 27.1 | 9 | 5.8 | 11 | 7.1 |
2002-2006 | 164 | 39 | 23.8 | 56 | 34.1 | 45 | 27.4 | 10 | 6.1 | 14 | 8.5 |
2001-2005 | 171 | 39 | 22.8 | 56 | 32.7 | 49 | 28.7 | 11 | 6.4 | 16 | 9.4 |
2000-2004 | 168 | 28 | 16.7 | 54 | 32.1 | 57 | 33.9 | 14 | 8.3 | 15 | 8.9 |
1999-2003 | 164 | 26 | 15.9 | 49 | 29.9 | 58 | 35.4 | 16 | 9.8 | 15 | 9.1 |
1998-2002 | 176 | 22 | 12.5 | 48 | 27.3 | 64 | 36.4 | 23 | 13.1 | 19 | 10.8 |
1997-2001 | 165 | 17 | 10.3 | 44 | 26.7 | 63 | 38.2 | 19 | 11.5 | 22 | 13.3 |
1996-2000 | 143 | 12 | 8.4 | 41 | 28.7 | 51 | 35.7 | 19 | 13.3 | 20 | 14.0 |
1995-1999 | 132 | 8 | 6.1 | 43 | 32.6 | 39 | 29.5 | 18 | 13.6 | 24 | 18.2 |
1994-1998 | 126 | 6 | 4.8 | 45 | 35.7 | 32 | 25.4 | 18 | 14.3 | 25 | 19.8 |
1993-1997 | 116 | 4 | 3.4 | 52 | 44.8 | 25 | 21.6 | 12 | 10.3 | 23 | 19.8 |
1992-1996 | 130 | 5 | 3.8 | 54 | 41.5 | 30 | 23.1 | 15 | 11.5 | 26 | 20.0 |
1991-1995 | 150 | 6 | 4.0 | 59 | 39.3 | 37 | 24.7 | 17 | 11.3 | 31 | 20.7 |
1990-1994 | 153 | 7 | 4.6 | 55 | 35.9 | 37 | 24.2 | 17 | 11.1 | 37 | 24.2 |
1989-1993 | 157 | 8 | 5.1 | 54 | 34.4 | 35 | 22.3 | 16 | 10.2 | 44 | 28.0 |
1988-1992 | 151 | 9 | 6.0 | 39 | 25.8 | 41 | 27.2 | 19 | 12.6 | 43 | 28.5 |
1987-1991 | 134 | 7 | 5.2 | 35 | 26.1 | 38 | 28.4 | 18 | 13.4 | 36 | 26.9 |
1986-1990 | 111 | 4 | 3.6 | 30 | 27.0 | 29 | 26.1 | 15 | 13.5 | 33 | 29.7 |
1985-1989 | 118 | 5 | 4.2 | 34 | 28.8 | 39 | 33.1 | 16 | 13.6 | 24 | 20.3 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |